In a multicenter randomized trial, tenecteplase did not improve vision recovery compared with aspirin when given within 4.5 hours of acute central retinal artery occlusion (CRAO). The ...

Concerns arise as Medisep 2 excludes essential eye treatment for age-related macular degeneration, risking vision for Kerala’s pensioners.

INDICATIONS EYLEA HD ® (aflibercept) Injection 8 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and ...

Intravenous tenecteplase administered within 4.5 hours after onset of central retinal artery occlusion does not improve vision recovery at 30 days compared with oral aspirin, according to a study ...

Tenecteplase failed to outperform aspirin for vision recovery when administered within 4.5 hours of onset of acute central ...

Central retinal artery occlusion can result in permanent vision loss. Effective treatment is lacking. We conducted a phase 3, double-blind, double-dummy, randomized, controlled trial involving ...

Laser-induced maculopathy occurs when bright, high-energy laser light damages the central part of the retina responsible for sharp vision.| India News ...

Sharon Fekrat discusses the complexities of antithrombotic use in wet AMD, highlighting the need for individualized treatment and future guideline development. Sharon Fekrat, MD, FACS, FASRS, ...

Kimora Hodges, 24, was sentenced to life without parole in connection with the 2022 murder of a 22-month-old she was babysitting Macomb County Sheriff's Office Kimora Hodges was sentenced to life ...

TARRYTOWN, N.Y., Nov. 19, 2025 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (REGN) today announced that the U.S. Food and Drug Administration (FDA) has approved EYLEA HD ® (aflibercept) ...

Department of Ophthalmology, Prince Sultan Military Medical City, Riyadh, Saudi Arabia. Systemic Lupus Erythematosus (SLE) is an autoimmune disease, affecting connective tissues, associated with a ...